New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
06:01 EDTICLR, CCRNCross Country Healthcare agrees to sell clinical trial services business
Cross Country Healthcare (CCRN) announced it has entered into an agreement to sell its clinical trial services business to ICON plc (ICLR) for $52M, plus an earn-out of up to $3.75M related to certain performance-based milestones. Consummation of the transaction is subject to the completion of certain closing conditions. This transaction is expected to be completed within the next 30 days. Cross Country Healthcare intends to use a portion of the net proceeds from this transaction to retire all of its outstanding bank debt.
News For CCRN;ICLR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 7, 2015
07:12 EDTICLRCancer Genetics announces partnership with ICON plc
Cancer Genetics (CGIX) announced that it has entered into a partnership with the Laboratory Services group of ICON plc (ICLR). ICON's Laboratory Services provide global testing services to the pharmaceutical, biotechnology and medical device industries. The partnership will provide clients access to combined expertise ranging from complex, oncology-focused genomic testing to core central laboratory analysis, project and data management and sample logistics on a global basis. Oncology testing services are central to CGI's business model and are also a core focus area for ICON Laboratory Services. Together, the two companies will leverage their respective expertise to provide key insights to the oncology drug development and clinical trial process: ICON's expertise in strategic development and in management and analysis of lab data from large-scale clinical programmes, and CGI's extensive knowledge in applying genomics and other advanced technologies focused on cancer. The partnership is focused on providing a comprehensive, integrated and efficient solution for laboratory testing for global oncology trials from Phase I through Phase IV.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use